Infections Clinical Trials

530 recruitingLast updated: June 17, 2026

There are 530 actively recruiting infections clinical trials across 79 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Paris, France, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Infections Trials at a Glance

530 actively recruiting trials for infections are listed on ClinicalTrialsFinder across 6 cities in 79 countries. The largest study group is Not Applicable with 156 trials, with the heaviest enrollment activity in New York, Paris, and Houston. Lead sponsors running infections studies include National Institute of Allergy and Infectious Diseases (NIAID), University Hospital, Strasbourg, France, and ViiV Healthcare.

Treatments under study

About Infections Clinical Trials

Looking for clinical trials for Infections? There are currently 61 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 530 trials

Recruiting

Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure

Lyme DiseaseChronic Lyme DiseasePregnancy Complications+3 more
Children's National Research Institute40 enrolled1 locationNCT06026969
Recruiting

Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections

bloodstream infectionPneumonia, BacterialS Maltophilia Infections
Instituto de Investigación Sanitaria Gregorio Marañón790 enrolled1 locationNCT07593547
Recruiting

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

PneumoniaInfectionsImmune System Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT00006150
Recruiting
Phase 1Phase 2

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NeutropeniaInfectionsWarts+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT00967785
Recruiting
Phase 2

Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

InfectionsAcute Respiratory Distress Syndrome
BioAegis Therapeutics Inc.600 enrolled70 locationsNCT05947955
Recruiting
Phase 1

Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.

InfluenzaAcute Respiratory Viral Infections
Valenta Pharm JSC36 enrolled1 locationNCT07645534
Recruiting

PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE

Antimicrobial Resistance (AMR)Gram-negative Infections
IRCCS Azienda Ospedaliero-Universitaria di Bologna60 enrolled2 locationsNCT06717594
Recruiting

Modeling Host-Pathogen Interaction Using Lymphoid Organoids

Staphylococcal Infections
National Institute of Allergy and Infectious Diseases (NIAID)500 enrolled2 locationsNCT06479837
Recruiting
Phase 2

Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Gram-Negative Bacterial Infections
Pfizer48 enrolled24 locationsNCT05639647
Recruiting

Diagnosis and Treatment of Leishmania Infections

LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID)289 enrolled1 locationNCT00344188
Recruiting

Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)

Urinary Tract InfectionsAntiobiotic StewardshipEmerging Infectious Disease
Centre Hospitalier Intercommunal Creteil330 enrolled3 locationsNCT07559318
Recruiting
Phase 3

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Cytomegalovirus InfectionsKidney Transplant InfectionPancreas Transplant
University of Wisconsin, Madison90 enrolled1 locationNCT06407232
Recruiting
Phase 3

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

InfectionsInjury LegAmputation+6 more
Major Extremity Trauma Research Consortium250 enrolled13 locationsNCT05699174
Recruiting
Phase 3

STI Testing to Enhance PrEP Use in Pregnancy

PregnancySexually Transmitted Infections (STIs)PrEP Adherence
Botswana Harvard AIDS Institute Partnership600 enrolled1 locationNCT06919614
Recruiting
Not Applicable

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

HIV InfectionsSubstance Use Disorders
Medical University of South Carolina50 enrolled1 locationNCT05816083
Recruiting
Phase 2

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Respiratory Syncytial Virus Infections
Shionogi192 enrolled73 locationsNCT07214571
Recruiting
Phase 1

R-MVST Cells for Treatment of Viral Infections

Epstein-Barr Virus InfectionsCytomegalovirus InfectionsBK Virus Infection+1 more
Columbia University36 enrolled1 locationNCT05183490
Recruiting

Epidemiological Characteristics and Clinical Burden of RSV Infection in Children Under 24 Months in Ho Chi Minh City (2026-2028)

Acute Respiratory Infections (ARIs)
Tam Anh Research Institute2,000 enrolled3 locationsNCT07640581
Recruiting
Phase 4

Trial of an AI-enabled Digital Stethoscope to Improve Antibiotic Stewardship

Respiratory Infections in Children
Johns Hopkins University2,500 enrolled1 locationNCT07362433
Recruiting
Phase 1Phase 2

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Systemic Inflammatory Response SyndromeSARS CoV-2Respiratory distress syndrome+2 more
PEACHES BIOTECH50 enrolled3 locationsNCT06684379